Eisai confirms that it has the right to terminate the Strategic Alliance and Development Agreement with Pfizer with respect to Aricept® upon consummation of Pfizer's acquisition of Wyeth.

Contact:
PR Department
Eisai Co., Ltd.
+81 - (0)3 - 3817 - 5120